PARTELLI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 2.474
EU - Europa 2.157
AS - Asia 1.630
SA - Sud America 174
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 4
Totale 6.527
Nazione #
US - Stati Uniti d'America 2.407
RU - Federazione Russa 870
SG - Singapore 666
GB - Regno Unito 551
CN - Cina 475
IT - Italia 161
VN - Vietnam 146
BR - Brasile 136
HK - Hong Kong 133
DE - Germania 123
SE - Svezia 95
FR - Francia 91
FI - Finlandia 84
IE - Irlanda 79
KR - Corea 60
CA - Canada 38
BD - Bangladesh 36
UA - Ucraina 25
TR - Turchia 18
IN - India 17
MX - Messico 17
NL - Olanda 17
BE - Belgio 16
ID - Indonesia 16
AR - Argentina 15
NG - Nigeria 15
PL - Polonia 13
JP - Giappone 12
TG - Togo 9
ES - Italia 8
IQ - Iraq 8
AT - Austria 7
BJ - Benin 6
CL - Cile 6
SA - Arabia Saudita 6
EC - Ecuador 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 4
ZA - Sudafrica 4
KH - Cambogia 3
KZ - Kazakistan 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
VE - Venezuela 3
BF - Burkina Faso 2
CO - Colombia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
TH - Thailandia 2
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
RS - Serbia 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.488
Città #
Southend 473
Singapore 363
Moscow 296
San Jose 277
Ashburn 246
Jacksonville 214
Chandler 200
Woodbridge 160
Ann Arbor 151
Hong Kong 132
Dallas 124
Council Bluffs 92
Houston 85
Beijing 79
Dublin 79
Verona 72
New York 58
Ho Chi Minh City 52
The Dalles 52
Los Angeles 43
Wilmington 42
Lawrence 37
Princeton 37
Jinan 30
Hanoi 27
Santa Clara 27
Buffalo 24
Shenyang 21
Nanjing 20
Helsinki 19
Munich 19
Milan 18
Redondo Beach 18
Sindelfingen 18
Hebei 17
Tianjin 17
Brussels 16
Toronto 16
Abuja 15
Chicago 15
Changsha 14
Columbus 14
Guangzhou 14
London 14
Ningbo 14
Seoul 14
Da Nang 13
Nanchang 13
Orem 13
Stockholm 13
Atlanta 12
Frankfurt am Main 12
Lancaster 12
San Francisco 12
São Paulo 12
Tokyo 12
Warsaw 12
Brooklyn 11
Haikou 11
Amsterdam 10
Montreal 10
Zhengzhou 10
Denver 9
Jakarta 9
Lomé 9
Taizhou 9
Jiaxing 8
Mexico City 8
Auburn Hills 6
Boardman 6
Bologna 6
Cotonou 6
Hangzhou 6
Shanghai 6
Ankara 5
Chennai 5
Fuzhou 5
Poplar 5
Rio de Janeiro 5
Rome 5
Seattle 5
Taiyuan 5
Tashkent 5
Turku 5
Vienna 5
Barnet 4
Cagliari 4
Düsseldorf 4
Fortaleza 4
Grafing 4
Haiphong 4
Norwalk 4
Padova 4
Paris 4
Phoenix 4
Querétaro 4
Baghdad 3
Borgo Valsugana 3
Dearborn 3
Dhaka 3
Totale 4.172
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 286
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 234
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Laparoscopic rectal resection for severe endometriosis of the mid and low rectum: technique and operative results. 188
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 180
Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections 179
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 176
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors 174
Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1. 171
Parenchyma-sparing resections for pancreatic neoplasms. 168
Pancreatic Cystic Endocrine Tumors: A Different Morphological Entity Associated with a Less Aggressive Behavior. 162
Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. 162
Middle pancreatectomy: indications, short- and long-term operative outcomes. 162
Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. 159
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 158
Extent of surgical resections for intraductal papillary mucinous neoplasms. 158
Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma. 156
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 154
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 149
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 149
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 149
Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. 142
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail - a Novel Prognostic Parameter for Patients Selection 140
Pleomorphic liposarcoma of the axilla metastatic to the pancreas. 136
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio 136
OBSERVATIONAL STUDY OF NATURAL HISTORY OF SMALL SPORADIC NONFUNCTIONING PANCREATIC NEUROENDOCRINE TUMORS 135
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters 135
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 133
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 133
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 131
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 129
Pancreatic cystic tumours: when to resect, when to observe 114
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors 114
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 113
Advanced Digestive Neuroendocrine Tumors: metastatic pattern is an independent factor affecting clinical outcome. 112
Rectal indomethacin to prevent post-ERCP pancreatitis. 110
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 108
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection 104
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 102
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 102
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms 99
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 96
Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development 96
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 87
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age 85
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 55
Totale 6.527
Categoria #
all - tutte 22.800
article - articoli 21.848
book - libri 0
conference - conferenze 506
curatela - curatele 0
other - altro 446
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022242 0 70 3 24 5 3 12 16 11 8 27 63
2022/2023556 50 52 70 77 39 123 14 40 65 2 16 8
2023/2024351 11 35 30 47 40 46 16 16 6 30 54 20
2024/2025907 52 45 23 171 55 28 53 31 141 56 90 162
2025/20262.857 198 107 149 482 761 183 314 129 231 167 56 80
2026/202789 29 60 0 0 0 0 0 0 0 0 0 0
Totale 6.527